These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33568896)

  • 1. New Approach in Ocular Drug Delivery: In vitro and ex vivo Investigation of Cyclodextrin-Containing, Mucoadhesive Eye Drop Formulations.
    Bíró T; Bocsik A; Jurišić Dukovski B; Gróf I; Lovrić J; Csóka I; Deli MA; Aigner Z
    Drug Des Devel Ther; 2021; 15():351-360. PubMed ID: 33568896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of prednisolone-containing eye drop formulations by cyclodextrin complexation and antimicrobial, mucoadhesive biopolymer.
    Bíró T; Horvát G; Budai-Szűcs M; Csányi E; Urbán E; Facskó A; Szabó-Révész P; Csóka I; Aigner Z
    Drug Des Devel Ther; 2018; 12():2529-2537. PubMed ID: 30147300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving corneal permeability of dexamethasone using penetration enhancing agents: First step towards achieving topical drug delivery to the retina.
    Thareja A; Leigh T; Hakkarainen JJ; Hughes H; Alvarez-Lorenzo C; Fernandez-Trillo F; Blanch RJ; Ahmed Z
    Int J Pharm; 2024 Jul; 660():124305. PubMed ID: 38852749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones.
    Gade SK; Shivshetty N; Sharma N; Bhatnagar S; Garg P; Venuganti VVK
    J Ocul Pharmacol Ther; 2018 Oct; 34(8):570-578. PubMed ID: 30136888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrin-enabled nepafenac eye drops with improved absorption open a new therapeutic window.
    Vincze A; Facskó R; Budai-Szűcs M; Katona G; Gyarmati B; Csorba A; Zelkó R; Nagy ZZ; Szente L; Balogh GT
    Carbohydr Polym; 2023 Jun; 310():120717. PubMed ID: 36925244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.
    Loftsson T; Stefánsson E
    Acta Ophthalmol Scand; 2002 Apr; 80(2):144-50. PubMed ID: 11952479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of celecoxib eye drop solution and microsuspension: A comparative investigation of binary and ternary cyclodextrin complexes.
    Jansook P; Kulsirachote P; Asasutjarit R; Loftsson T
    Carbohydr Polym; 2019 Dec; 225():115209. PubMed ID: 31521306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
    Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
    Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement and inhibition effects on the corneal permeability of timolol maleate: Polymers, cyclodextrins and chelating agents.
    Rodríguez I; Vázquez JA; Pastrana L; Khutoryanskiy VV
    Int J Pharm; 2017 Aug; 529(1-2):168-177. PubMed ID: 28652172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: Synthesis, in vitro/vivo evaluation, and mechanism.
    Sun X; Sheng Y; Li K; Sai S; Feng J; Li Y; Zhang J; Han J; Tian B
    Acta Biomater; 2022 Jan; 138():193-207. PubMed ID: 34757228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking.
    Conde Penedo A; Díaz Tomé V; Fernández Ferreiro A; González Barcia M; Otero Espinar FJ
    Eur J Pharm Biopharm; 2021 May; 162():12-22. PubMed ID: 33667681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system.
    Senjoti FG; Timmins P; Conway BR; Smith AM
    Eur J Pharm Biopharm; 2020 Sep; 154():1-7. PubMed ID: 32599271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone.
    Bary AR; Tucker IG; Davies NM
    Eur J Pharm Biopharm; 2000 Sep; 50(2):237-44. PubMed ID: 10962233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supramolecular cyclodextrin complex: Diversity, safety, and applications in ocular therapeutics.
    Chaudhari P; Ghate VM; Lewis SA
    Exp Eye Res; 2019 Dec; 189():107829. PubMed ID: 31605685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time.
    Nagai N; Nakazawa Y; Ito Y; Kanai K; Okamoto N; Shimomura Y
    Biol Pharm Bull; 2017; 40(7):1055-1062. PubMed ID: 28674248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular Drug Delivery System-based on Solid Nanoparticles].
    Nagai N
    Yakugaku Zasshi; 2021; 141(1):47-53. PubMed ID: 33390447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug.
    Sayed S; Elsayed I; Ismail MM
    Int J Pharm; 2018 Oct; 549(1-2):249-260. PubMed ID: 30077759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
    Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
    Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.